• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature

tetano

Editor, Senior Moderator
J Crit Care. 2018 Jun 9;47:61-64. doi: 10.1016/j.jcrc.2018.06.001. [Epub ahead of print]
[h=1]When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature.[/h] H?kimian G[SUP]1[/SUP], Jovanovic T[SUP]2[/SUP], Br?chot N[SUP]2[/SUP], Lebreton G[SUP]3[/SUP], Leprince P[SUP]3[/SUP], Trouillet JL[SUP]2[/SUP], Schmidt M[SUP]2[/SUP], Nieszkowska A[SUP]2[/SUP], Besset S[SUP]2[/SUP], Chastre J[SUP]2[/SUP], Combes A[SUP]2[/SUP], Luyt CE[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]PURPOSE:[/h] To describe patients with refractory cardiogenic shock related to influenza B virus myocarditis rescued by venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO).
[h=4]MATERIAL AND METHODS:[/h] Consecutive patients hospitalized in our unit for influenza-associated myocarditis were prospectively included. We also conducted a systematic MEDLINE database literature review through the PubMed search engine, between 1946 and 2017.
[h=4]RESULTS:[/h] We report the cases of 4 young patients with fulminant myocarditis requiring VA-ECMO for 6 [5-8] days. Influenza B virus was detected in all patients, either in nasopharyngeal sampling or bronchoalveolar lavage fluid. The 4 patients received oseltamivir. Heart function recovery allowed ECMO device removal without cardiac sequelae in all 4 patients. Systematic review retrieved 184 cases of influenza-associated myocarditis, most cases associated with H1N1 type-A infection during the 2009 pandemic. Forty eight cases of influenza myocarditis-associated cardiogenic shock requiring mechanical circulatory support including 3 cases due to influenza B virus were described. Mean duration of mechanical circulatory support was 8.5 ? 6 days and mortality rate was 33%.
[h=4]CONCLUSIONS:[/h] Influenza myocarditis is a rare but reversible cause of cardiogenic shock amenable to VA-ECMO rescue. Early antiviral therapy and ECMO support should be considered for patients with fulminant myocarditis during an influenza epidemic.
Copyright ? 2018. Published by Elsevier Inc.


[h=4]KEYWORDS:[/h] Cardiogenic shock; Extracorporeal membrane oxygenation; Influenza; Mechanical circulatory support; Myocarditis

PMID: 29929152 DOI: 10.1016/j.jcrc.2018.06.001
 
Back
Top Bottom